Results 201 to 210 of about 2,229,234 (312)

Setting up an Intra‐Arterial Chemotherapy Center in a Low‐Resource Country in Sub‐Saharan Africa

open access: yesPublic Health Challenges, Volume 5, Issue 4, December 2026.
Ghana established West Africa's first intra‐arterial chemotherapy service for retinoblastoma through a public–private partnership between Korle Bu Teaching Hospital and Euracare, delivering 32 treatment sessions for 10 children. Strategic partnerships, training, and phased implementation can make this vision‐ and life‐saving therapy achievable in low ...
Vera Adobea Essuman   +13 more
wiley   +1 more source

Identification of favorable subgroups of pediatric high-hyperdiploid acute lymphoblastic leukemia-A retrospective multinational study. [PDF]

open access: yesHemasphere
Attarbaschi A   +31 more
europepmc   +1 more source

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1421-1441, December 2026.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto   +12 more
wiley   +1 more source

Correlation between myeloproliferative diseases and T cell acute lymphoblastic leukemia: a case report and literature review. [PDF]

open access: yesHematol Transfus Cell Ther
Weihermann V   +7 more
europepmc   +1 more source

Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1531-1540, December 2026.
ABSTRACT Introduction Central venous catheter (CVC) insertion is frequently required in patients with haematological diseases. Despite limited evidence, thrombocytopenia often prompts prophylactic platelet transfusion before catheterisation. Methods We conducted an observational before‐and‐after study including the first non‐tunnelled CVC insertion ...
Mathias Lazarevic Lindblad   +8 more
wiley   +1 more source

RNA Sequencing Technologies in Acute Lymphoblastic Leukemia: A Comparative Technical Review. [PDF]

open access: yesCurr Issues Mol Biol
Koutra M   +7 more
europepmc   +1 more source

Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1485-1499, December 2026.
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley   +1 more source

Results of second-line therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]

open access: yesCancer
Kantarjian H   +11 more
europepmc   +1 more source

Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non‐Hodgkin Lymphoma on Reproduction Patterns

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1601-1611, December 2026.
ABSTRACT Concerns about treatment‐related fertility impairment are common among young adult lymphoma survivors. Evidence on the impact of treatment for aggressive non‐Hodgkin lymphoma (NHL) on future childbearing is limited, although many individuals of reproductive age are affected.
Stefanie Antonilli   +10 more
wiley   +1 more source

Toxicity of Cytarabine Intravenous Constant Rate Infusion in Cats With Lymphoma

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 4, Page 830-840, December 2026.
ABSTRACT Cytarabine intravenous constant rate infusion (IV CRI) toxicity in cats with lymphoma has not been well documented. We aimed to assess toxicities following cytarabine IV CRI as a single‐agent or within a multiagent protocol in cats with lymphoma. Medical records of cats with lymphoma treated with cytarabine IV CRI, with documented dose, route,
Rachel Hanford   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy